• 
• 
• english
• français
• русский

Archivo: Grupo de Investigación

 

2000 Session of the Research Group of the Standing Technical Committee of EuFMD
Borovets, Bulgaria
5 - 8 September 2000

 

Informe Completo (en inglés)
Apéndices
1. Emergence of a Pandemic Strain of Foot-and-Mouth Disease Virus Serotype O
2. Pathogenicity of O/JPN/2000 to susceptible animals
3. Origin of recent outbreaks in North africa the Middle East and Europe
4. FMD situation in Turkey in 2000
5. Minimal aerosol infectious dose of the 01 Lausanne strain of foot-and-mouth disease virus for pigs
6. Antigenic and genetic characterization of foot-and-mouth disease type O viruses from the Far East
7. Genetically diverse isolates of type O foot-and-mouth disease virus exhibit remarkable amino acid conservation at their neutralizing antigenic sites
8. Early pathogenesis of foot-and-mouth disease in pigs: a quantitative time-course study using a newly developed TaqMan RT-PCR assay
9. IgA response of cattle to FMDV infection in probing and saliva samples 2004-2005
10. Guidelines for the control and eradication of foot-and-mouth disease in livestock populations with a high density of sheep
11. Possible introduction of FMD with sheep intestines from FMD countries
12. Peculiarities of FMD buffer zone functioning in the CIS countries
13. Results of seromonitoring studies in FMD buffer zone of the CIS countries
14. Sensitivity of primary cells immortalized by oncogene transfection for the isolation of foot-and-mouth disease virus
15. Interferon and foot-and-mouth disease virus
16. Type-independent detection of foot-and-mouth disease virus by ELISA using monoclonal antibodies that bind to the animoterminus of capsid protein VP2
17. Serotyping of foot-and-mouth disease virus isolated from western buffer zone with coagglutination test as an alternative to CFT and ELISA
18. Evaluation of a chromatographic strip test for foot-and-mouth disease virus antigen detection
19. Development of antigen capture RT-PCR for foot-and-mouth disease virus antigen detection
20. RT-PCR probing ELISAs for the diagnosis and typing of foot-and-mouth disease virus using our newly developed SNAP (Simple and Aqueous Phase) hybridization
21. Evaluation of RT-PCR procedures for the diagnosis of clinical samples of foot-and-mouth disease virus (serotypes O, A, C and Asia 1) under EU Concerted Action PL 98-4032
22. Diagnosis of persisting infections of foot-and-mouth disease virus in cattle: IgA ELISA, virus isolation and RT-PCR
23. Spray-drying of inactivated FMDV antigens for diagnostic use
24. RA solid phase competition ELISA for the detection of antibody to foot-and-mouth disease virus
25. Animal Production and Health Section of the Joint FAO/IAEA Programme of Nuclear Techniques in Agriculture (Vienna) Coordinated Research Project on: " The use of non-structural proteins of foot-and-mouth disease virus (FMDV)to differentiate between vaccinated and infected animals
26. Detection of antibodies against non-structural proteins of FMDV in Bulgaria
27. Improved indirect ELISA based on the 3ABC polyprotein for differentiating infection from vaccination in foot-and-mouth disease
28. Indirect ELISA using recombinant VP1 capsid protein for the serodifferentiation of foot-and-mouth disease virus infected animals
29. FAO Collaborative Study Phase XVI: Establishing reference standards for FMD serology
30. Comparison of FMDV neutralization tests using three different cell lines: validation of the new FAO reference sera
31. Longevity of the antibody response in pigs and sheep following a single administration of high potency emergency FMD vaccines
32. Enhancement of the immune response induced by the inclusion of saponine in oil adjuvanted vaccines against foot-and-mouth disease
33. Experimental vaccination against FMDV with immunocomplexes
34. Formaldehyde enhances BEI-inactivation rates of foot-and-mouth disease(FMD) virus by at least a ten-fold
35. Validating the efficacy of emergency foot-and-mouth disease vaccines in sheep following virus challenge using the non-structural polyprotein 3ABC MAT-ELISA
36. Experimental FMD infections in pigs: a possible design for a PD50 experiment
37.The second report of the European Pharmacopoeia Working Group. Present and future contacts with the European Pharmacopoeia and with EMEA
38. Preliminary results from the EuFMD Expert Elicitation Workshop on risk of introduction of FMD to Europe
39. List of Participants